ID: ALA3288074

Max Phase: Preclinical

Molecular Formula: C30H48Na2O8S2

Molecular Weight: 602.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=C(C)[C@@H]1CC[C@@]2(C)[C@H]1[C@H]1CC[C@@H]3[C@@]4(C)CC[C@H](OS(=O)(=O)[O-])C(C)(C)[C@@H]4CC[C@@]3(C)[C@]1(C)C[C@@H]2OS(=O)(=O)[O-].[Na+].[Na+]

Standard InChI:  InChI=1S/C30H50O8S2.2Na/c1-18(2)19-11-14-28(6)24(38-40(34,35)36)17-30(8)20(25(19)28)9-10-22-27(5)15-13-23(37-39(31,32)33)26(3,4)21(27)12-16-29(22,30)7;;/h19-25H,1,9-17H2,2-8H3,(H,31,32,33)(H,34,35,36);;/q;2*+1/p-2/t19-,20+,21-,22+,23-,24-,25+,27-,28+,29+,30+;;/m0../s1

Standard InChI Key:  BMXCVAGNZYUFIB-CTNMRGLWSA-L

Associated Targets(non-human)

Acetylcholinesterase 657 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cholinesterase 8742 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 602.86Molecular Weight (Monoisotopic): 602.2947AlogP: 6.65#Rotatable Bonds: 5
Polar Surface Area: 127.20Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: -1.46CX Basic pKa: CX LogP: 6.33CX LogD: 1.57
Aromatic Rings: 0Heavy Atoms: 40QED Weighted: 0.26Np Likeness Score: 2.38

References

1. Castro MJ, Richmond V, Romero C, Maier MS, Estévez-Braun A, Ravelo AG, Faraoni MB, Murray AP..  (2014)  Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.,  22  (13): [PMID:24835788] [10.1016/j.bmc.2014.04.050]

Source